Cite
HARVARD Citation
Karlowsky, J. et al. (2018). In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme. Journal of antimicrobial chemotherapy. pp. 1872-1879. [Online].